# Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma

> **NCT01168752** · PHASE1 · COMPLETED · sponsor: **Debiopharm International SA** · enrollment: 81 (actual)

## Conditions studied

- Cancer
- Neoplasms
- Solid Tumors
- Lymphoma

## Interventions

- **DRUG:** Debio 0932

## Key facts

- **NCT ID:** NCT01168752
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2014-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168752, "Study of Debio 0932 in Patients With Advanced Solid Tumours or Lymphoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01168752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*